Kelly Lawrence W & Associates’s Regeneron Pharmaceuticals REGN Stock Holding History

Kelly Lawrence W & Associates’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$138K	Hold	263	–	–	0.04%	89
2025 Q1	$167K	Hold	263	–	–	0.04%	88
2024 Q4	$187K	Buy	263 +25	+11%	+$17.8K	0.04%	86
2024 Q3	$250K	Hold	238	–	–	0.06%	77
2024 Q2	$250K	Buy	238 +4	+2%	+$4.2K	0.06%	74
2024 Q1	$225K	Sell	234 -6	-3%	-$5.78K	0.05%	70
2023 Q4	$211K	Hold	240	–	–	0.05%	75
2023 Q3	$198K	Sell	240 -125	-34%	-$103K	0.05%	73
2023 Q2	$285K	Sell	365 -20	-5%	-$15.6K	0.07%	67
2023 Q1	$316K	Hold	385	–	–	0.09%	65
2022 Q4	$278K	Hold	385	–	–	0.08%	66
2022 Q3	$265K	Hold	385	–	–	0.07%	76
2022 Q2	$228K	Hold	385	–	–	0.06%	78
2022 Q1	$269K	Hold	385	–	–	0.06%	69
2021 Q4	$243K	Hold	385	–	–	0.05%	72
2021 Q3	$233K	Hold	385	–	–	0.05%	73
2021 Q2	$215K	Hold	385	–	–	0.05%	76
2021 Q1	$182K	Buy	385 +34	+10%	+$16.1K	0.04%	73
2020 Q4	$170K	Sell	351 -845	-71%	-$409K	0.07%	53
2020 Q3	$669K	Buy	1,196 +20	+2%	+$11.2K	0.2%	44
2020 Q2	$733K	Sell	1,176 -325	-22%	-$203K	0.15%	42
2020 Q1	$733K	Sell	1,501 -2,950	-66%	-$1.44M	0.18%	44
2019 Q4	$1.67M	Hold	4,451	–	–	0.26%	39
2019 Q3	$1.24M	Buy	4,451 +335	+8%	+$93K	0.21%	43
2019 Q2	$1.29M	Sell	4,116 -185	-4%	-$57.9K	0.22%	43
2019 Q1	$1.77M	Sell	4,301 -1,410	-25%	-$579K	0.32%	39
2018 Q4	$2.13M	Sell	5,711 -19,949	-78%	-$7.45M	0.46%	36
2018 Q3	$10.4M	Buy	25,660 +435	+2%	+$176K	1.71%	27
2018 Q2	$8.7M	Buy	25,225 +300	+1%	+$103K	1.6%	27
2018 Q1	$8.58M	Sell	24,925 -340	-1%	-$117K	1.63%	26
2017 Q4	$9.5M	Hold	25,265	–	–	1.75%	23
2017 Q3	$11.3M	Buy	25,265 +45	+0.2%	+$20.1K	2.15%	23
2017 Q2	$12.4M	Buy	25,220 +680	+3%	+$334K	2.45%	20
2017 Q1	$9.51M	Buy	24,540 +24,390	+16,260%	+$9.45M	1.96%	24
2016 Q4	$55K	Hold	150	–	–	0.01%	123
2016 Q3	$60K	Hold	150	–	–	0.01%	126
2016 Q2	$52K	Buy	+150	New	+$52K	0.01%	135